Isolation of tetracycline-resistant clinical Helicobacter pylori without mutations in 16S rRNA gene in Bangladesh

Microbiology and Immunology

Volumn 52, Issue 10, 2008, Pages 508-511

  Khan, Rasel ^a,e   Nahar, Shamsun ^a   Mukhopadhyay, Asish K ^c   Berg, Douglas E ^d   Ahmad, Mian Mashhud ^b   Okamoto, Keinosuke ^e   Balakrish Nair, G ^a,c   Rahman, Motiur ^a,f  

^a ICDDRB Laboratory Sciences Division   (Bangladesh)

^b DHAKA MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OKAYAMA UNIVERSITY   (Japan)

^f FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

16S rRNA gene mutation; Helicobacter pylori; Resistance; Tetracycline

Indexed keywords

RNA 16S; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BANGLADESH; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA GENE; CHEMISTRY; DRUG EFFECT; GENETIC TRANSFORMATION; GENETICS; HELICOBACTER INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION;

HELICOBACTER PYLORI;

ANTI-BACTERIAL AGENTS; BANGLADESH; BASE SEQUENCE; DNA, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; TETRACYCLINE; TETRACYCLINE RESISTANCE; TRANSFORMATION, GENETIC;

EID: 58149149967     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00062.x     Document Type: Article

References (12)

1. Dailidiene D., Bertoli M.T., Miciuleviciene J., Mukhopadhyay A.K., Dailide G., Pascasio M.A. et al. (2002). Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 46: 3940-6.
2. Nahar S., Mukhopadhyay A.K., Khan R., Ahmad M.M., Datta S., Chattopadhyay S. et al. (2004). Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol 42: 4856-8.
3. Kwon D.H., Kim J.J., Lee M., Yamaoka Y., Kato M., Osato M.S. et al. (2000). Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 44: 3203-5.
4. Rahman M., Mukhopadhyay A.K., Nahar S., Datta S., Ahmad M.M., Sarker S. et al. (2003). DNA-level characterization of Helicobacter pylori strains from patients with overt disease and with benign infections in Bangladesh. J Clin Microbiol 41: 2008-14.
5. Trieber C.A., Taylor D.E. (2002). Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184: 2131-40.
6. Wu J.Y., Kim J.J., Reddy R., Wang W.M., Graham D.Y., Kwon D.H. (2005). Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 49: 578-83.
7. Khan A.M., von Gierke U., Hossain M.S., Fuchs G.J. (2003). Tetracycline in the treatment of cholera caused by Vibrio cholerae O1 resistant to the drug in vitro. J Health Popul Nutr 21: 76-8.
8. Jeong J.Y., Mukhopadhyay A.K., Akada J.K., Dailidiene D., Hoffman P.S., Berg D.E. (2001). Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J Bacteriol 183: 5155-62.
9. Khan R., Nahar S., Sultana J., Ahmad M.M., Rahman M. (2004). T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 48: 3567-69.
10. Kwon D.H., Dore M.P., Kim J.J., Kato M., Lee M., Wu J.Y. et al. (2003). High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother 47: 2169-78.
11. van Amsterdam K., Bart A., van der Ende A. (2005). A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 49: 1477-82.
12. Kutschke A., de Jonge B.L. (2005). Compound efflux in Helicobacter pylori. Antimicrob Agents Chemother 49: 3009-10.